Last quarter (Q4 2022), Tissue Regenix's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Tissue Regenix's net income was $―. See Tissue Regenix’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	$ 24.48M	$ 19.75M	$ 16.47M	$ 13.03M	$ 11.62M
Cost of Revenue	-	-	$ 11.27M	$ 8.90M	$ 7.01M	$ 5.70M
Gross Profit	-	$ 24.48M	$ 8.48M	$ 7.57M	$ 6.02M	$ 5.92M
Operating Expense	-	$ 26.55M	$ 12.57M	$ 12.93M	$ 13.20M	$ 14.18M
Operating Income	-	$ -2.07M	$ -4.10M	$ -5.36M	$ -7.18M	$ -8.27M
Net Non Operating Interest Income Expense	-	$ -733.00K	$ 689.00K	$ -568.00K	$ -460.00K	$ -190.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	$ -2.83M	$ -5.14M	$ -13.15M	$ -7.66M	$ -8.88M
Tax Provision	-	$ -232.00K	$ -157.00K	$ -684.00K	$ -554.00K	$ -620.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	$ -2.69M	$ -4.79M	$ -12.47M	$ -6.97M	$ -8.19M
Basic EPS	-	$ -40.00	-	$ >-0.01	$ >-0.01	$ >-0.01
Diluted EPS	-	$ -40.00	-	$ >-0.01	$ >-0.01	$ >-0.01
Basic Average Shares	-	$ 7.03B	$ 7.03B	$ 4.45B	$ 1.17B	$ 1.17B
Diluted Average Shares	-	$ 7.03B	$ 7.03B	$ 4.45B	$ 1.17B	$ 1.17B
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	$ 149.00K	$ 213.00K	$ 85.00K
Total Expenses	-	$ 26.55M	$ -23.84M	$ 21.83M	$ 20.21M	$ 19.89M
Net Income From Continuing And Discontinued Operation	-	$ -2.69M	$ -4.79M	$ -12.47M	$ -6.97M	$ -8.19M
Normalized Income	-	$ -3.06M	$ -4.94M	$ -5.62M	$ -6.95M	$ -7.79M
Interest Expense	-	-	-	$ 571.00K	$ 477.00K	$ 262.00K
EBIT	-	$ -2.09M	$ -4.45M	$ -12.58M	$ -7.18M	$ -8.62M
EBITDA	-	$ -952.00K	$ -4.45M	$ -11.53M	$ -6.14M	$ -7.44M

Currency in USD

Tissue Regenix Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing